The only company that makes the machines that print AI chips.
ASML is the only maker of EUV lithography machines, the tools needed to print the most advanced chips. Sales rose 55% to a record €11.7B (about $13.4B) last quarter, and management says planned supply will not meet customer demand in 2027 or 2028. The catches: China is still about a fifth of sales and faces tighter US export rules, and the stock trades at about 41 times trailing earnings, flattered by a one-off gain.
Price, last 12 months
Daily closes of the NASDAQ-listed shares with the 50-day average. Each ADR is one ordinary share. ASML has closed between about $1,550 and $1,990 since June.
Revenue and margins, by quarter
Revenue in US$ millions, with GAAP gross margin on the right axis. ASML reports in euros on a calendar year; each quarter is converted at that quarter's average EUR/USD rate (from about 1.01 in Q3 2022 to about 1.15–1.17 in 2025–26), so part of the dollar growth since 2025 is the stronger euro. EPS is per share (1 ADR = 1 share), converted the same way. The last bar is the midpoint of the €14.2–15.2B Q4 2026 guide at about 1.12 $/€.
| Quarter | Ended | Revenue, US$M | YoY | Gross margin | Op. margin | EPS (GAAP) |
|---|
Watch list
What moves the thesis, sorted by direction.
Demand outruns supply
Management now expects planned supply to fall short of demand in both 2027 and 2028, and some customers want to place orders for 2029–30. ASML is adding about 30% EUV and DUV capacity in 2027 and is studying more than the 30% planned for 2028.
Upgrades and pricing
Installed base sales of €3.29B beat guidance by about €400M as customers bought productivity upgrades, lifting gross margin to a record 57.5%. Installed base sales should grow about 50% this year.
No bookings number
ASML stopped reporting quarterly orders in 2026; the last figure was €13.2B in Q4 2025. Management says order momentum has risen every quarter this year, and Q3 free cash flow of €11.4B shows large down payments arrived.
A big Q4
The €14.2–15.2B Q4 guide is about 51% above last year's €9.7B at the midpoint, with gross margin around 57%. LSEG consensus had been €14.19B, and the 2026 range narrowed to €44–45B.
China and the MATCH Act
China was 23% of Q3 system sales (14% in Q2) and should be about 20% of full-year sales. The proposed US MATCH Act would block immersion DUV sales to China and could limit servicing there.
Valuation
At about 41 times trailing earnings (27 forward) the stock prices in strong growth. It fell 3.9% on results day even though the Q4 guide beat, and sits about 17% below its 52-week high.
Calendar
Interim dividend (Nasdaq ex-date)
€1.88 per share, announced with Q3 results on Oct 14 and paid Nov 4.
Q4 2026 earnings
Full-year results and the 2027 outlook, including any update on 2028 capacity. Guide: €14.2–15.2B sales, ~57% gross margin. ASML has not confirmed the date.
Sources
- Q3 2026 results and Q4 guidance (ASML)
- Q3 2026 earnings call transcript (Motley Fool)
- Q3 2026 slides: mix, regions and cash flow (Investing.com)
- Q4 guide vs LSEG consensus (Reuters)
- Q3 2026 vs estimates (Zacks)
- Quarterly income statement in euros (Stock Analysis)
- Price, market cap, forward P/E and 52-week range: Stocklake; EUR/USD averages: FMP, as of Oct 15, 2026